ArticleJournal of the American Heart Association2024

Nonsteroidal Mineralocorticoid Receptor Antagonist Finerenone Improves Diastolic Dysfunction in Preclinical Nondiabetic Chronic Kidney Disease.

Ixchel Lima Posada et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.